Evets Drugs Private Limited
About Evets Drugs Private Limited
Data last updated:
Evets Drugs Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 June 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21002MH2023PTC404460.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Banshidhar Kanhaiyalal and Saurabh Kumar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹85.64 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹17.97 Lakh (net margin -21%) and EBITDA of -₹17.33 Lakh (EBITDA margin -20.2%).
As per MCA filings, the company has open charges of ₹3.5 Cr on record.
Company details
Contact details
Evets Drugs Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address604 6th Floor Inizio Cts, 479 479/1 To 479/17, Mumbai, Maharashtra, India – 400069
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Evets Drugs is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Evets Drugs Private Limited, buy the company report.
Financials of Evets Drugs Private Limited
FY 2025 filings availableEvets Drugs Private Limited reported revenue of ₹85.64 Lakh (up 522397% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹17.33 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹17.97 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -20.2% | |
| Net Profit Margin | -21% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Evets Drugs Private Limited, buy the company report.
Board of directors of Evets Drugs Private Limited
Evets Drugs has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Banshidhar Kanhaiyalal Also directs: Sriram Healthcare Private Limited, Acme Therapeutics (I) Private Limited, Prosperity Drugs Private Limited and 2 more | Director | 07 Jun 2023 | 3 Years 5 Months | Current |
| Saurabh Kumar | Director | 07 Jun 2023 | 3 Years 5 Months | Current |
| Atul Hareshwar Kane | Director | 07 Jun 2023 | 3 Years 5 Months | Current |
| Murlidhar Kanhaiyalal Also directs: Sriram Healthcare Private Limited, Prosperity Drugs Private Limited, Evets Packaging Private Limited and 1 more | Director | 07 Jun 2023 | 3 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Sep 2023 | 100786777 | Hdfc Bank Limited | ₹3.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Evets Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Evets Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Evets Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Evets Drugs Private Limited has 5 board changes on record since 2023: 5 appointments. The latest: Atul Hareshwar Kane was appointed as Director on 07 Jun 2023.
Frequently asked questions
Evets Drugs is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 June 2023 (3+ years old) and is registered under CIN U21002MH2023PTC404460.
Evets Drugs has 4 current directors:
- Banshidhar Kanhaiyalal - Director
- Saurabh Kumar - Director
- Atul Hareshwar Kane - Director
- Murlidhar Kanhaiyalal - Director
The latest financial statements of Evets Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Evets Drugs is U21002MH2023PTC404460. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Evets Drugs was incorporated on 07 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
Atul Hareshwar Kane was appointed as Director on 07 Jun 2023. Banshidhar Kanhaiyalal was appointed as Director on 07 Jun 2023. Murlidhar Kanhaiyalal was appointed as Director on 07 Jun 2023. Evets Drugs has 5 board changes on record in total.
The registered office of Evets Drugs is at 604 6th Floor Inizio Cts, 479 4791 To 47917, Mumbai, Maharashtra, India – 400069.
Evets Drugs operates in the pharma industry, in the drug formulation and development segment.
Evets Drugs has open charges of ₹3.5 Cr and no satisfied charges on record as per latest MCA filings.
Evets Drugs can be reached at its registered office: 604 6th Floor Inizio Cts, 479 4791 To 47917, Mumbai, Maharashtra, India – 400069.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
